Werlabs Competitors and Similar CompaniesClear all
Werlabs's competitors and similar companies include Adaptive Biotechnologies, BioSenic, Mobidiag and Nzumbe.
 Werlabs Werlabs is a company that offers health check-ups via blood-testing, reviewed online by healthcare professionals. |  Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. |  BioSenic BioSenic (formerly known as Bone Therapeutics) is a biotechnology company specializing in the treatment of osteo-articular diseases using cell therapy. |  Mobidiag Mobidiag is a biotechnology company that provides solutions for in vitro diagnostics of infectious diseases. |  Nzumbe Nzumbe is a company that develops technologies to identify and target disease-causing epigenetic events that lead to cancer, neurological disorders, and other diseases. | |
Founding Date | Founding Date 2013 | Founding Date 2009 | Founding Date 2006 | Founding Date 2000 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Stockholm, SE HQ | Locations Seattle, US HQ New York, US South San Francisco, US | Locations Charleroi, BE HQ Charleroi, BE | Locations Espoo, FI HQ Paris, FR Vallentuna, SE Loudwater, GB | Locations Portland, US HQ Portland, US |
Employees | Employees 723% increase | Employees 70910% decrease | Employees 20 | Employees 7312% decrease | Employees 2 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $277m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $71.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $205.6m (FY, 2025) | Gross profit €3.1m (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($59.5m) (FY, 2025) | Net income (€6.7m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 525m | Total funding raised $ 10.4m | Total funding raised $ 74m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Adaptive Biotechnologies
HQ
Seattle, US
Employees
709↓ 10% decrease
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View companyBioSenic
HQ
Charleroi, BE
Employees
20
BioSenic (formerly known as Bone Therapeutics) is a biotechnology company specializing in the treatment of osteo-articular diseases using cell therapy.
View companyMobidiag
HQ
Espoo, FI
Employees
73↓ 12% decrease
Mobidiag is a biotechnology company that provides solutions for in vitro diagnostics of infectious diseases.
View companyNzumbe
HQ
Portland, US
Employees
2
Nzumbe is a company that develops technologies to identify and target disease-causing epigenetic events that lead to cancer, neurological disorders, and other diseases.
View company